PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS (FR0010949404 – STNT), a medical technology company commercializing the world’s first and only Self-Apposing® stent to treat acute myocardial infarction (AMI), today announced that it has entered into a Standby Equity Facility with Société Générale, exercisable by tranches at STENTYS’ discretion, as authorized by the Shareholders’ Meeting of May 15, 2013.
Help employers find you! Check out all the jobs and post your resume.
